DE69933444T2 - Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen - Google Patents

Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen Download PDF

Info

Publication number
DE69933444T2
DE69933444T2 DE69933444T DE69933444T DE69933444T2 DE 69933444 T2 DE69933444 T2 DE 69933444T2 DE 69933444 T DE69933444 T DE 69933444T DE 69933444 T DE69933444 T DE 69933444T DE 69933444 T2 DE69933444 T2 DE 69933444T2
Authority
DE
Germany
Prior art keywords
seq
polypeptide
polynucleotide
basb027
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69933444T
Other languages
German (de)
English (en)
Other versions
DE69933444D1 (de
Inventor
Carlota Vinals-Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811945.6A external-priority patent/GB9811945D0/en
Priority claimed from GBGB9905304.3A external-priority patent/GB9905304D0/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Application granted granted Critical
Publication of DE69933444D1 publication Critical patent/DE69933444D1/de
Publication of DE69933444T2 publication Critical patent/DE69933444T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69933444T 1998-06-03 1999-05-31 Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen Expired - Lifetime DE69933444T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9811945.6A GB9811945D0 (en) 1998-06-03 1998-06-03 Novel compounds
GB9811945 1998-06-03
GBGB9905304.3A GB9905304D0 (en) 1999-03-08 1999-03-08 Novel compounds
GB9905304 1999-03-08
PCT/EP1999/003822 WO1999063093A2 (en) 1998-06-03 1999-05-31 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses

Publications (2)

Publication Number Publication Date
DE69933444D1 DE69933444D1 (de) 2006-11-16
DE69933444T2 true DE69933444T2 (de) 2007-03-29

Family

ID=26313784

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933444T Expired - Lifetime DE69933444T2 (de) 1998-06-03 1999-05-31 Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen

Country Status (22)

Country Link
US (3) US6803043B1 (cg-RX-API-DMAC7.html)
EP (1) EP1082435B1 (cg-RX-API-DMAC7.html)
JP (1) JP4503177B2 (cg-RX-API-DMAC7.html)
KR (3) KR100830282B1 (cg-RX-API-DMAC7.html)
CN (1) CN1311820B (cg-RX-API-DMAC7.html)
AT (1) ATE341628T1 (cg-RX-API-DMAC7.html)
AU (1) AU738896B2 (cg-RX-API-DMAC7.html)
BR (1) BR9911609A (cg-RX-API-DMAC7.html)
CA (1) CA2331196A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105820T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296086B6 (cg-RX-API-DMAC7.html)
DE (1) DE69933444T2 (cg-RX-API-DMAC7.html)
DK (1) DK1082435T3 (cg-RX-API-DMAC7.html)
ES (1) ES2274627T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0102235A3 (cg-RX-API-DMAC7.html)
IL (2) IL139951A0 (cg-RX-API-DMAC7.html)
NO (1) NO327201B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ508617A (cg-RX-API-DMAC7.html)
PL (1) PL198031B1 (cg-RX-API-DMAC7.html)
PT (1) PT1082435E (cg-RX-API-DMAC7.html)
TR (1) TR200003608T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999063093A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US20030157522A1 (en) * 2001-11-09 2003-08-21 Alain Boudreault Methods and reagents for peptide-BIR interaction screens
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
BE1006377A3 (fr) 1992-11-24 1994-08-09 Raffinerie Tirlemontoise Sa Procede de separation d'une composition polydispersee de saccharides, produits obtenus par ce procede et utilisation des produits obtenus dans des compositions alimentaires.
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics

Also Published As

Publication number Publication date
US20040265331A1 (en) 2004-12-30
US6803043B1 (en) 2004-10-12
CA2331196A1 (en) 1999-12-09
PL198031B1 (pl) 2008-05-30
NO20006112L (no) 2001-02-02
NO20006112D0 (no) 2000-12-01
ATE341628T1 (de) 2006-10-15
KR20070089890A (ko) 2007-09-03
AU4373299A (en) 1999-12-20
IL139951A (en) 2008-08-07
IL139951A0 (en) 2002-02-10
AU738896B2 (en) 2001-09-27
PT1082435E (pt) 2007-01-31
WO1999063093A2 (en) 1999-12-09
BR9911609A (pt) 2001-02-06
KR100830282B1 (ko) 2008-05-16
WO1999063093A3 (en) 2000-03-02
TR200003608T2 (tr) 2001-04-20
HK1037209A1 (en) 2002-02-01
KR100911277B1 (ko) 2009-08-11
EP1082435A2 (en) 2001-03-14
NZ508617A (en) 2003-08-29
HUP0102235A1 (hu) 2001-10-28
EP1082435B1 (en) 2006-10-04
US7641910B2 (en) 2010-01-05
US20100143412A1 (en) 2010-06-10
ES2274627T3 (es) 2007-05-16
CY1105820T1 (el) 2011-02-02
CZ296086B6 (cs) 2006-01-11
KR20060129108A (ko) 2006-12-14
HUP0102235A3 (en) 2004-10-28
CN1311820A (zh) 2001-09-05
CZ20004510A3 (cs) 2001-07-11
KR20010052552A (ko) 2001-06-25
PL345193A1 (en) 2001-12-03
DE69933444D1 (de) 2006-11-16
NO327201B1 (no) 2009-05-11
CN1311820B (zh) 2011-11-16
JP4503177B2 (ja) 2010-07-14
JP2002517199A (ja) 2002-06-18
DK1082435T3 (da) 2007-02-05

Similar Documents

Publication Publication Date Title
DE69928925T2 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
DE69935213T2 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
DE69918446T2 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
DE69927017T2 (de) Verbindungen aus moraxella catarrhalis
DE69928947T2 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
DE69921649T2 (de) Moraxella catarrhalis pilq proteine
DE69928931T2 (de) Moraxella catarrhalis polynukleotide und polypeptide
ES2274627T3 (es) Proteinas y genes de moraxella catarrhalis, antigenos, anticuerpos y usos.
DE69919693T2 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
DE60024456T2 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
DE60019614T2 (de) Moraxella catarrhalis antigen basb117
DE60034463T2 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
DE60019613T2 (de) Moraxella catarrhalis antigen basb120
DE60035788T2 (de) Polypeptide aus moraxella (branhamella) catarrhalis
EP1105492A1 (en) Cloning of basb023 antigen from moraxella catarrhalis
MXPA01002671A (en) Moraxella catarrhalis basb034 polypeptides and uses thereof
HK1037209B (en) Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses

Legal Events

Date Code Title Description
8364 No opposition during term of opposition